Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease

Infection with novel SARS-CoV-2 carries significant morbidity and mortality in patients with pulmonary compromise, such as lung cancer, autoimmune disease, and pneumonia. For early stages of mild to moderate disease, care is entirely supportive. Antiviral drugs such as remdesivir may be of some bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Paul A., Newman, Steven A., Oshry, Lauren J., Glassman, Robert H., Leone, Ashton M., Reichel, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476338/
https://www.ncbi.nlm.nih.gov/pubmed/32873175
http://dx.doi.org/10.1177/1753466620951053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476338/
https://www.ncbi.nlm.nih.gov/pubmed/32873175
http://dx.doi.org/10.1177/1753466620951053

Ejemplares similares